The U.S. Food and Drug Administration (FDA) has given its stamp of approval to a new cystic fibrosis drug called “Orkambi,” developed by Vertex Pharmaceuticals Inc. Orkambi is Vertex’s second cystic fibrosis drug. The first, “Kalydeco,” was... Read More